March 23 (Reuters) - Allergan Plc:
* AMGEN AND ALLERGAN RECEIVE POSITIVE CHMP OPINION FOR ABP 980 (BIOSIMILAR HERCEPTIN®) FOR THE TREATMENT OF THREE TYPES OF CANCER
* AMGEN RECOMMENDED FOR APPROVAL FOR SAME INDICATIONS AS HERCEPTIN
* AMGEN CHMP POSITIVE OPINION FOR ABP 980 WILL NOW BE REVIEWED BY EUROPEAN COMMISSION Source text for Eikon: Further company coverage:
